$39.3 Billion Worldwide Blood Preparation Industry to 2027 - Impact of COVID-19 on the Market

Dublin, May 26, 2021 (GLOBE NEWSWIRE) -- The "Blood Preparation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Blood Preparation estimated at US$39.3 Billion in the year 2020, is projected to reach a revised size of US$56.6 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027.

Whole Blood, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$25.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood Components segment is readjusted to a revised 5.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $10.6 Billion, While China is Forecast to Grow at 8.6% CAGR

The Blood Preparation market in the U.S. is estimated at US$10.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.1 Billion by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Blood Derivatives Segment to Record 5.7% CAGR

In the global Blood Derivatives segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$6.2 Billion in the year 2020 will reach a projected size of US$8.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.7 Billion by the year 2027, while Latin America will expand at a 6.1% CAGR through the analysis period.

Select Competitors (Total 33 Featured):

• AstraZeneca plc

• Baxter International Inc

• Bristol-Myers Squibb Company

• GlaxoSmithKline plc

• Leo Pharma A/S

• Pfizer, Inc

• Sanofi

• Xiamen Hisunny Chemical Co., LTD

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights

• World Market Trajectories

• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

• UNITED STATES

• REST OF EUROPE

• AUSTRALIA

• INDIA

• SOUTH KOREA

• REST OF ASIA-PACIFIC

• ARGENTINA

• BRAZIL

• MEXICO

• REST OF LATIN AMERICA

• IRAN

• ISRAEL

• SAUDI ARABIA

• UNITED ARAB EMIRATES

• REST OF MIDDLE EAST

• AFRICA

IV. COMPETITION

• Total Companies Profiled: 33

For more information about this report visit https://www.researchandmarkets.com/r/gr0h5w

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900